Ponnusamy Saravanan
Ponnusamy Saravanan is an expert in Endocrinology at George Eliot Hospital NHS Trust (United Kingdom). As of November 2026, ScienceLeadR ranks Ponnusamy Saravanan in the top 1% of experts worldwide for Pregnancy Complications, Diabetes Mellitus and Glucose Metabolism Disorders. Ponnusamy Saravanan has authored 179 publications, the most recent in 2026, and is an investigator in 8 clinical trials, 1 of them ongoing. SLR score: 776 (community average: 125). How the SLR is computed.
LeadR Profile
Endocrinology
Subspecialties: Obstetrics - Gynecology - Nutrition
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2007 - 2026
Number : 179
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Prediabetes before pregnancy: implications for risk stratification and research. PMID 42158986 — diabetes mellitus, diabetes, gestational, pregnancy, insulin resistance, prediabetic state, research | Curr Opin Endocrinol Diabetes Obes | 2026 | 0 |
| Epigenome-wide placental methylation landscapes in relation to antenatal depressive symptoms. PMID 42744221 — patient health questionnaire, genes, pregnancy, genome, signs and symptoms, epigenome, placenta, neurodevelopment | Neurochem Int | 2026 | 0 |
| Translating Real-World Safety and Implementation Gaps Into a Deployment-Derived AI Readiness Preimplementation Checklist for NHS Health Care Providers: Checklist Development Study. PMID 42804536 — trust, patient safety, safety, translating, health personnel, learning, artificial intelligence, implementation science, workforce | JMIR AI | 2026 | 0 |
| Incidence of gestational diabetes and inequalities in adverse pregnancy outcomes in England: contemporary, cross sectional observational study of 2.7 million births. PMID 42553832 — diabetes mellitus, diabetes, gestational, pregnancy, mothers, parturition, incidence, emergencies, pregnancy outcome, gestational age, covid-19, odds ratio, diagnosis, pandemics, premature birth, infant | BMJ Med | 2026 | 0 |
| Editorial for Cardiology CME Edition (July 2026). PMID 42480937 — cardiology, clinical medicine | Clin Med (Lond) | 2026 | 0 |
Clinical Studies 8
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide NCT06897475 — diabetes mellitus, double-blind method, obesity, therapeutics, overweight, diabetes mellitus, type 2, semaglutide | Phase 2 | Recruiting | 2025 |
LeadR Networks
Main global connection map